Treatment with recombinant human erythropoietin induces a moderate rise in hematocrit and thrombin antithrombin in healthy subjects
- 1 July 1995
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 79 (1) , 125-129
- https://doi.org/10.1016/0049-3848(95)91520-u
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Effect of Erythropoietin Treatment on Physical Exercise Capacity and on Renal Function in Predialytic Uremic PatientsNephron, 1992
- Effect of erythropoietin administration on mammal aerobic powerScandinavian Journal of Medicine & Science in Sports, 1991
- Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy menJournal of Internal Medicine, 1991
- Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group.BMJ, 1990
- Effects of Exercise on Parameters of Blood Coagulation, Platelet Function and the Prostaglandin SystemSports Medicine, 1988
- Bleeding and thrombosis in the myeloproliferative disordersBlood, 1984
- An immunoassay for human D dimer using monoclonal antibodiesThrombosis Research, 1983
- Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 + 2 fragment and thrombin--antithrombin complexBlood, 1982
- Rapid radioimmunoassay of human fibrinopeptide A — Removal of cross-reacting fibrinogen with bentoniteThrombosis Research, 1980